Regulatory Considerations for Nasal Sprays Sold as Medical Devices

Regulatory

Regulatory Considerations for Nasal Sprays Sold as Medical Devices

Classification, CE marking, technical documentation and registration outside Europe: the regulatory points to consider before distributing or launching a nasal spray.

By Neomedis Editorial Team · · 2 min read

Many saline and seawater nasal sprays are regulated as medical devices rather than as medicines. For distributors and brand owners, this has practical consequences: which documents exist, who is responsible for what, and how long it takes to register a product in a new country.

This article is general information and does not replace advice from regulatory specialists or the competent authorities.

The European framework: the MDR

In the European Union, medical devices are governed by Regulation (EU) 2017/745 on medical devices (MDR), which has applied since 26 May 2021. A device may only be placed on the EU market once it complies with the regulation and bears the CE marking.

Classification

Each device is classified (class I, IIa, IIb or III) according to the classification rules of the MDR, based mainly on its intended purpose, how long it is used and how it interacts with the body. The class determines the conformity assessment route: for most class I devices the manufacturer declares conformity itself, while higher classes require the involvement of a notified body.

Because classification depends on the intended purpose, the claims made on packaging and marketing materials matter: they must be consistent with the product's technical documentation.

Key documents

  • Technical documentation describing the device, its design, manufacturing, risk management and performance.
  • EU declaration of conformity signed by the manufacturer.
  • Certificates issued by a notified body, when required by the device class.
  • Labelling and instructions for use, in the languages required by each country.

Vigilance and post-market surveillance

Manufacturers must monitor their devices once on the market and report serious incidents to the competent authorities. Labels and instructions for use provide a contact for reporting incidents; distributors should make sure their teams know the procedure.

Registration outside the EU

Outside the EU, requirements vary widely. Some countries rely on CE marking as part of their registration file; others require a full local registration, a local representative or importer licence, and specific labelling. Timelines can range from a few weeks to many months.

Practical advice for distributors

  1. Confirm with your local authority how the product is classified in your country.
  2. Ask the manufacturer early which documents are available for registration.
  3. Align packaging claims with the intended purpose stated in the documentation.
  4. Plan artwork, translations and registration before fixing a launch date.

Neomedis nasal sprays are CE-marked medical devices, and our regulatory team provides the documents necessary for registration. Learn about our quality and regulatory support.

Go further: what to check before choosing a private label nasal spray manufacturer.

More insights

Looking for a reliable partner for your next ENT healthcare product?

Discuss your project with our team. Tell us about your market and we will come back to you with the options that fit.